Rituximab, IVIg, and Tetracosactide (ACTH1-24) Combination Immunotherapy ("RITE-CI") for Pediatric Opsoclonus-Myoclonus Syndrome: Immunomarkers and Clinical Observations

Pranzatelli, MR; Tate, ED; Alber, M; Awadalla, M; Blumkin, L; Lina, ES; Leiz, S; Moser, J

Pranzatelli, MR (reprint author), Natl Pediat Neuroinflammat Org Inc, 12001 Res Pkwy,Suite 236, Orlando, FL 32826 USA.

NEUROPEDIATRICS, 2018; 49 (2): 123

Abstract

Opsoclonus-myoclonus syndrome (OMS) is a neuroinflammatory disorder with pervasive morbidity that warrants better treatments. Twelve children with mod......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索